Melissa S. Thebeau

Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

Geoffrey T. Gibney, Ragini R. Kudchadkar, Ronald C. DeConti et al. · Clinical Cancer Research · 2014 · 256 citations · Full text

Medicine, Immunology, Oncology +17

Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study

Grant A. McArthur, Michele Maio, Ana Arance et al. · Annals of Oncology · 2016 · 246 citations · Full text

Medicine, Oncology, Pharmacology +12

Management of skin adverse events associated with immune checkpoint inhibitors in patients with melanoma

Melissa S. Thebeau, Krista M. Rubin, Matthias Hofmann et al. · Journal of the American Association of Nurse Practitioners · 2017 · 16 citations

Medicine, Dermatology, Oncology +17

Adjuvant nivolumab (NIVO) plus ipilimumab (IPI) for resected high-risk stages IIIC/IV melanoma (MEL).

Nikhil I. Khushalani, Young‐Chul Kim, Geoffrey T. Gibney et al. · Journal of Clinical Oncology · 2016 · 10 citations

Pharmacy, Oncology, Pharmacology +17